CA-SYNACK
5.8.2019 18:02:10 CEST | Business Wire | Press release
New York Times reporter Jessica Bennett observed that the 2020 female Democratic candidates have largely avoided the phrase “glass ceiling” , prompting linguist Robin Lakoff to speculate that the phrase just “seems tired”. On the debate floor, action-oriented and empowering words like “persist” are replacing phrases like “glass ceiling” and the “stuck-ness” implicitly suggested by them. It’s not just in politics that women are intentionally working toward changing society’s perception of them in the workplace; it’s happening in cybersecurity too.
Today, women make up only 20% of the cybersecurity industry’s workforce. This largely untapped demographic could be the saving grace for an industry desperate for skilled labor and on pace to hit 3.5 million unfilled jobs by 2021 according to Cybersecurity Ventures. This is why today Synack launches their “Courageous Women CISO Initiative” which aims to encourage more women to enter the cybersecurity field; offer support by creating a strong network for women; and provide a platform for women to share their voice in the boardroom, across the aisles in policy, and from the podium at leading industry conferences. Synack will build upon efforts that aim to close the talent gap in other ways (like encouraging young women to enter into STEM fields) by empowering women to get to the forefront of cybersecurity innovation and lead the charge in making our organizations more secure. The company is also encouraging more women to apply to their elite Synack Red Team , the world’s best and most trusted crowd of ethical hackers.
“When the concept of harnessing a crowd of ethical hackers was novel, Synack found that women CISOs were 2x more likely to adopt crowdsourced security, which showed that female security leaders are willing to be bold and courageous when facing decisions that can make their organizations more secure. Cybersecurity is a field that needs more diversity in thought and action, and women are an underrepresented group. We need more female leaders in the field who have successfully navigated the industry to be examples and mentors to newcomers,” said Aisling MacRunnels, Synack CMO and Courageous Women CISO Initiative Chair.
Synack’s initiative aims to connect and empower security’s female change-makers through a series of networking events and opportunities to speak from the podium at industry-renowned conferences. Synack has partnered with Microsoft/M12, CyberWire and now Booz Allen Hamilton to host popular women’s networking events at Black Hat USA, RSA Conference, and Billington Cybersecurity Summit; later this week, the company will host their 3rd annual Women’s Brunch at Black Hat USA. Through these efforts, Synack aims to …
- Close the talent gap in cybersecurity by increasing the number of women entering the industry by 50% by 2022.
- Increase the number of women speaking at industry conferences, so that the percentage of female speakers is on par with the percentage of male speakers by 2022.
After the women’s lunch at the RSA Conference 2019, partners M12 and CyberWire said, “We had a great time with the Synack team today - if only every lunch could be filled with so many impressive women! A big thank you to our amazing hosts: Lisa Nelson, Microsoft Ventures and Aisling MacRunnels, Synack,” (M12), and “It is our pleasure to support and empower women in the field of cybersecurity!” (Cyberwire).
Synack’s Courageous Women CISO initiative was developed to bring female security leaders and executives together to support each other in having a bigger impact in their companies and industry. Through this initiative, Synack’s goal is to create an environment that fosters authentic conversations and provides a support network for women in cybersecurity. Let’s change the status quo in cybersecurity together - RSVP for upcoming events for women and learn more about Synack’s Courageous Women CISO Initiative here: https://go.synack.com/courageous-women-ciso.html .
About Synack
Synack, the most trusted crowdsourced security platform, delivers continuous and scalable penetration testing with actionable results. The company combines the world's most skilled and trusted ethical hackers with AI-enabled technology to create an efficient and effective security solution. Headquartered in Silicon Valley with regional offices around the world, Synack protects leading global banks, federal agencies, DoD classified assets, and close to $1 trillion in Fortune 500 revenue. Synack was founded in 2013 by former US Department of Defense hackers Jay Kaplan, CEO, and Dr. Mark Kuhr, CTO. For more information, please visit www.synack.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190805005459/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
